Xigris (Zy-gris, drotrecogin alfa), a new biotech drug for treating severe sepsis

January 2002

Lilly is now marketing Xigris (Zy-gris, drotrecogin alfa), a new biotech drug for treating severe sepsis.

Until now the main treatment for severe sepsis was antibiotics.

Xigris is the first drug shown to improve survival in cases of severe septic infections. It reduces deaths by about 6%...or saves one life for every 16 patients who are treated.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Statin Comparison Chart--New generics for lovastatin (Mevacor) will hit the market
new COX-2 inhibitor called Bextra (valdecoxib)
Neurology & Pain Percocet now comes in two new strengths
Migraine how to pick a triptan
warning about possible hepatic failure with Serzone
Focalin, a new stimulant for attention deficit hyperactivity disorder (ADHD)
Infectious Diseases teenagers and adults with persistent cough actually have pertussis (whooping cough)
Infectious Diseases new injectable antibiotic called Invanz (IN-vance, ertapenem)
fluoxetine (Prozac, etc) is beneficial for some patients with Raynaud's phenomenon
Sepsis Xigris (Zy-gris, drotrecogin alfa), a new biotech drug for treating severe sepsis
Sepsis controlling hyperglycemia with insulin reduces sepsis in critically ill patients
Cardiology Antioxidants are out, now B vitamins are in for heart disease
Cardiology stronger warnings about serious arrhythmias when using droperidol (Inapsine)
Vaccines whether it's safe for warfarin patients to get influenza or pneumococcal vaccines
Vaccines Not enough adults with asthma are getting the flu vaccine
Supplements Kava's days might be numbered
Practice annual new drug chart for 2001
Practice annual new drug chart for 2001
Practice annual new drug chart for 2001
Practice annual new drug chart for 2001

Xigris (Zy-gris, drotrecogin alfa), a new biotech drug for treating severe sepsis

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Table of Contents